Cargando…
The Heme Oxygenase System Rescues Hepatic Deterioration in the Condition of Obesity Co-Morbid with Type-2 Diabetes
The prevalence of non-alcoholic fatty-liver disease (NAFLD) is increasing globally. NAFLD is a spectrum of related liver diseases that progressive from simple steatosis to serious complications like cirrhosis. The major pathophysiological driving of NAFLD includes elevated hepatic adiposity, increas...
Autores principales: | , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2013
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3829851/ https://www.ncbi.nlm.nih.gov/pubmed/24260182 http://dx.doi.org/10.1371/journal.pone.0079270 |
_version_ | 1782291402232692736 |
---|---|
author | Salley, Tatiana Ntube Mishra, Manish Tiwari, Shuchita Jadhav, Ashok Ndisang, Joseph Fomusi |
author_facet | Salley, Tatiana Ntube Mishra, Manish Tiwari, Shuchita Jadhav, Ashok Ndisang, Joseph Fomusi |
author_sort | Salley, Tatiana Ntube |
collection | PubMed |
description | The prevalence of non-alcoholic fatty-liver disease (NAFLD) is increasing globally. NAFLD is a spectrum of related liver diseases that progressive from simple steatosis to serious complications like cirrhosis. The major pathophysiological driving of NAFLD includes elevated hepatic adiposity, increased hepatic triglycerides/cholesterol, excessive hepatic inflammation, and hepatocyte ballooning injury is a common histo-pathological denominator. Although heme-oxygenase (HO) is cytoprotective, its effects on hepatocyte ballooning injury have not been reported. We investigated the effects of upregulating HO with hemin or inhibiting it with stannous-mesoporphyrin (SnMP) on hepatocyte ballooning injury, hepatic adiposity and inflammation in Zucker-diabetic-fatty rats (ZDFs), an obese type-2-diabetic model. Hemin administration to ZDFs abated hepatic/plasma triglycerides and cholesterol, and suppressed several pro-inflammatory cytokines and chemokines including, TNF-α, IL-6, IL-1β, macrophage-inflammatory-protein-1α (MIP-1α) and macrophage-chemoattractant-protein-1 (MCP-1), with corresponding reduction of the pro-inflammatory M1-phenotype marker, ED1 and hepatic macrophage infiltration. Correspondingly, hemin concomitantly potentiated the protein expression of several markers of the anti-inflammatory macrophage-M2-phenotype including ED2, IL-10 and CD-206, alongside components of the HO-system including HO-1, HO-activity and cGMP, whereas the HO-inhibitor, SnMP abolished the effects. Furthermore, hemin attenuated liver histo-pathological lesions like hepatocyte ballooning injury and fibrosis, and reduced extracellular-matrix/profibrotic proteins implicated in liver injury such as osteopontin, TGF-β1, fibronectin and collagen-IV. We conclude that hemin restore hepatic morphology by abating hepatic adiposity, suppressing macrophage infiltration, inflammation and fibrosis. The selective enhancement of anti-inflammatory macrophage-M2-phenotype with parallel reduction of pro-inflammatory macrophage-M1-phenotype and related chemokines/cytokines like TNF-α, IL-6, IL-1β, MIP-1α and MCP-1 are among the multifaceted mechanisms by which hemin restore hepatic morphology. |
format | Online Article Text |
id | pubmed-3829851 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2013 |
publisher | Public Library of Science |
record_format | MEDLINE/PubMed |
spelling | pubmed-38298512013-11-20 The Heme Oxygenase System Rescues Hepatic Deterioration in the Condition of Obesity Co-Morbid with Type-2 Diabetes Salley, Tatiana Ntube Mishra, Manish Tiwari, Shuchita Jadhav, Ashok Ndisang, Joseph Fomusi PLoS One Research Article The prevalence of non-alcoholic fatty-liver disease (NAFLD) is increasing globally. NAFLD is a spectrum of related liver diseases that progressive from simple steatosis to serious complications like cirrhosis. The major pathophysiological driving of NAFLD includes elevated hepatic adiposity, increased hepatic triglycerides/cholesterol, excessive hepatic inflammation, and hepatocyte ballooning injury is a common histo-pathological denominator. Although heme-oxygenase (HO) is cytoprotective, its effects on hepatocyte ballooning injury have not been reported. We investigated the effects of upregulating HO with hemin or inhibiting it with stannous-mesoporphyrin (SnMP) on hepatocyte ballooning injury, hepatic adiposity and inflammation in Zucker-diabetic-fatty rats (ZDFs), an obese type-2-diabetic model. Hemin administration to ZDFs abated hepatic/plasma triglycerides and cholesterol, and suppressed several pro-inflammatory cytokines and chemokines including, TNF-α, IL-6, IL-1β, macrophage-inflammatory-protein-1α (MIP-1α) and macrophage-chemoattractant-protein-1 (MCP-1), with corresponding reduction of the pro-inflammatory M1-phenotype marker, ED1 and hepatic macrophage infiltration. Correspondingly, hemin concomitantly potentiated the protein expression of several markers of the anti-inflammatory macrophage-M2-phenotype including ED2, IL-10 and CD-206, alongside components of the HO-system including HO-1, HO-activity and cGMP, whereas the HO-inhibitor, SnMP abolished the effects. Furthermore, hemin attenuated liver histo-pathological lesions like hepatocyte ballooning injury and fibrosis, and reduced extracellular-matrix/profibrotic proteins implicated in liver injury such as osteopontin, TGF-β1, fibronectin and collagen-IV. We conclude that hemin restore hepatic morphology by abating hepatic adiposity, suppressing macrophage infiltration, inflammation and fibrosis. The selective enhancement of anti-inflammatory macrophage-M2-phenotype with parallel reduction of pro-inflammatory macrophage-M1-phenotype and related chemokines/cytokines like TNF-α, IL-6, IL-1β, MIP-1α and MCP-1 are among the multifaceted mechanisms by which hemin restore hepatic morphology. Public Library of Science 2013-11-15 /pmc/articles/PMC3829851/ /pubmed/24260182 http://dx.doi.org/10.1371/journal.pone.0079270 Text en © 2013 Salley et al http://creativecommons.org/licenses/by/4.0/ This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are properly credited. |
spellingShingle | Research Article Salley, Tatiana Ntube Mishra, Manish Tiwari, Shuchita Jadhav, Ashok Ndisang, Joseph Fomusi The Heme Oxygenase System Rescues Hepatic Deterioration in the Condition of Obesity Co-Morbid with Type-2 Diabetes |
title | The Heme Oxygenase System Rescues Hepatic Deterioration in the Condition of Obesity Co-Morbid with Type-2 Diabetes |
title_full | The Heme Oxygenase System Rescues Hepatic Deterioration in the Condition of Obesity Co-Morbid with Type-2 Diabetes |
title_fullStr | The Heme Oxygenase System Rescues Hepatic Deterioration in the Condition of Obesity Co-Morbid with Type-2 Diabetes |
title_full_unstemmed | The Heme Oxygenase System Rescues Hepatic Deterioration in the Condition of Obesity Co-Morbid with Type-2 Diabetes |
title_short | The Heme Oxygenase System Rescues Hepatic Deterioration in the Condition of Obesity Co-Morbid with Type-2 Diabetes |
title_sort | heme oxygenase system rescues hepatic deterioration in the condition of obesity co-morbid with type-2 diabetes |
topic | Research Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3829851/ https://www.ncbi.nlm.nih.gov/pubmed/24260182 http://dx.doi.org/10.1371/journal.pone.0079270 |
work_keys_str_mv | AT salleytatianantube thehemeoxygenasesystemrescueshepaticdeteriorationintheconditionofobesitycomorbidwithtype2diabetes AT mishramanish thehemeoxygenasesystemrescueshepaticdeteriorationintheconditionofobesitycomorbidwithtype2diabetes AT tiwarishuchita thehemeoxygenasesystemrescueshepaticdeteriorationintheconditionofobesitycomorbidwithtype2diabetes AT jadhavashok thehemeoxygenasesystemrescueshepaticdeteriorationintheconditionofobesitycomorbidwithtype2diabetes AT ndisangjosephfomusi thehemeoxygenasesystemrescueshepaticdeteriorationintheconditionofobesitycomorbidwithtype2diabetes AT salleytatianantube hemeoxygenasesystemrescueshepaticdeteriorationintheconditionofobesitycomorbidwithtype2diabetes AT mishramanish hemeoxygenasesystemrescueshepaticdeteriorationintheconditionofobesitycomorbidwithtype2diabetes AT tiwarishuchita hemeoxygenasesystemrescueshepaticdeteriorationintheconditionofobesitycomorbidwithtype2diabetes AT jadhavashok hemeoxygenasesystemrescueshepaticdeteriorationintheconditionofobesitycomorbidwithtype2diabetes AT ndisangjosephfomusi hemeoxygenasesystemrescueshepaticdeteriorationintheconditionofobesitycomorbidwithtype2diabetes |